Related Experiment Videos

Mechanisms that may be involved in calcium tolerance of the diabetic heart

A Ziegelhöffer1, T Ravingerová, J Styk

  • 1Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovak Republic.

Insights

Diabetic hearts show increased calcium tolerance due to protein glycation, which enhances free radical formation and crosslinking in sarcolemma proteins. This adaptive mechanism protects against calcium paradox injury in diabetic cardiomyopathy.

Area of Science:

  • Biochemistry
  • Cardiology
  • Diabetology

Background:

  • Diabetes mellitus is associated with cardiac dysfunction, including impaired membrane properties and increased calcium tolerance (iCaT).
  • The molecular mechanisms underlying iCaT in diabetic hearts, particularly the role of non-enzymatic protein glycation, remain incompletely understood.
  • Diabetic cardiomyopathy (DH) presents with compensated functional and structural changes, offering a model to study adaptive mechanisms.

Purpose of the Study:

  • To elucidate the molecular alterations, specifically non-enzymatic glycation of sarcolemma (SL) proteins, contributing to iCaT in compensated DH.
  • To investigate the role of glycation-induced free radical formation and protein crosslinking in the adaptive response of diabetic hearts to calcium paradox (Ca-Pa).

Main Methods:

  • Induction of insulin-dependent diabetes (DIA) in rats using streptozotocin, followed by insulin treatment.
  • Assessment of blood parameters (glucose, lipids, glycohemoglobin) and isolated heart sarcolemma (SL) properties (ATPase activities, membrane fluidity, protein glycation, fructosamine content).
  • Evaluation of cardiac tolerance to Ca-Pa, a model of calcium overload, in isolated perfused hearts.

Main Results:

  • Diabetic hearts (DH) demonstrated significantly higher recovery rates (>83%) after Ca-Pa compared to non-diabetic controls (0%).
  • DH exhibited preserved SL ATPase activities and (Na,K)-ATPase activation kinetics post-Ca-Pa, correlating with their iCaT.
  • Resorcylidene aminoguanidine (RAG) partially prevented glycation effects and completely normalized SL membrane fluidity, but reduced iCaT, suggesting glycation's protective role.

Conclusions:

  • Glycation-induced enhancement of free radical formation and protein crosslinking in SL proteins appears to be a key adaptive mechanism contributing to iCaT in compensated DH.
  • These glycation-related alterations may represent a 'positive' adaptive response, enhancing cardiac resilience against calcium overload injury.
  • Targeting glycation pathways could offer novel therapeutic strategies for managing diabetic cardiomyopathy.

Related Concept Videos